This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Walnut consumption and cardiovascular risk

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Walnut consumption and cardiovascular risk

There is evidence that (1,2):

  • more frequent consumption of nuts has been associated with lower CVD (cardiovascular disease)
  • findings of small randomized controlled trials suggested cholesterol-lowering effects of nuts

The WAHA study (Walnuts and Healthy Aging) (3)

  • was conducted; a 2-center (Spain and California, USA), 2-year, parallel-group randomized controlled trial in which the effects of walnut-supplemented diet were examined in healthy elderly individuals
  • changes in lipoproteins were prespecified secondary outcomes
  • cognitive healthy elders (63-79 years) without major comorbidities were included
  • participants (n=628) were randomized to a walnut-free or walnut-supplemented diet (approximately 15% of energy, 30-60 g/d)
  • compliance with the diet was good with a stable body weight in both groups

Study results (3):

  • compared to the walnut-free group, participants in the walnut group had decreased (mg/dL) total cholesterol (mean -8.5 [95%CI: -11.2 to -5.4]), LDL-c (mean -4.3 [95%CI: -6.6 to -1.6]) and intermediate-density lipoprotein cholesterol (mean -1.3 [95%CI: -1.5 to -1.0]), corresponding to 4.4%, 3.6% and 16.8% reductions., respectively.
  • levels of triglycerides and high-density lipoprotein cholesterol were unchanged.
  • total LDL particles and small LDL particle number were decreased in the walnut group by 4.3% and 6.1%, respectively.
  • LDL-c reduction by walnut diet was more pronounced in men than in women (7.9% in men vs. 2.6% in women, P-interaction=0.007)

In the WAHA study, incorporation of walnuts to a diet in elderly individuals resulted in modest reductions of LDL-c, total cholesterol and IDL-c compared to a walnut-free diet.

The study authors concluded that:

  • "..On the basis of associations ascertained in cohort studies, the observed shift of the lipoprotein subclass phenotype suggests a reduction of lipoprotein-related CVD risk by long-term consumption of walnuts, which provides novel mechanistic insight for their potential cardiovascular benefit beyond effects on the standard lipid panel...."

Reference:

  • Becerra-Tomas N et al. Nut consumption and incidence of cardiovascular diseases and cardiovascular disease mortality: a meta-analysis of prospective cohort studies. Nutr Rev. 2019;77:691-709. doi: 10.1093/nutrit/nuz042
  • Sabate J, Oda K, Ros E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med. 2010;170:821-827. doi: 10.1001/archinternmed.2010.79
  • Rajaram S et al. Effects of Walnut Consumption for 2 Years on Lipoprotein Subclasses Among Healthy Elders – Findings from the WAHA Randomized Controlled trial Circulation 2021;144:00-00. DOI:10.1161/CIRCULATIONAHA.121.054051

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.